JP2019528271A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528271A5 JP2019528271A5 JP2019508842A JP2019508842A JP2019528271A5 JP 2019528271 A5 JP2019528271 A5 JP 2019528271A5 JP 2019508842 A JP2019508842 A JP 2019508842A JP 2019508842 A JP2019508842 A JP 2019508842A JP 2019528271 A5 JP2019528271 A5 JP 2019528271A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gene
- deletion
- smallpox
- chikungunya
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012217 deletion Methods 0.000 claims 8
- 230000037430 deletion Effects 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 241000700647 Variola virus Species 0.000 claims 6
- 230000004048 modification Effects 0.000 claims 6
- 238000012986 modification Methods 0.000 claims 6
- 230000002238 attenuated effect Effects 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 201000009182 Chikungunya Diseases 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 108010076039 Polyproteins Proteins 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- 241000907316 Zika virus Species 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 101150017902 A39R gene Proteins 0.000 claims 2
- 241000282994 Cervidae Species 0.000 claims 2
- 208000004293 Chikungunya Fever Diseases 0.000 claims 2
- 241001502567 Chikungunya virus Species 0.000 claims 2
- 101150044623 D13L gene Proteins 0.000 claims 2
- 108091027544 Subgenomic mRNA Proteins 0.000 claims 2
- 230000005847 immunogenicity Effects 0.000 claims 2
- 208000000666 Fowlpox Diseases 0.000 claims 1
- 241000700629 Orthopoxvirus Species 0.000 claims 1
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000001455 Zika Virus Infection Diseases 0.000 claims 1
- 208000035332 Zika virus disease Diseases 0.000 claims 1
- 208000020329 Zika virus infectious disease Diseases 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 claims 1
- HUSUHZRVLBSGBO-UHFFFAOYSA-L calcium;dihydrogen phosphate;hydroxide Chemical compound O.[Ca+2].OP([O-])([O-])=O HUSUHZRVLBSGBO-UHFFFAOYSA-L 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 208000007089 vaccinia Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016903295A AU2016903295A0 (en) | 2016-08-19 | Viral Vaccines | |
| AU2016903295 | 2016-08-19 | ||
| PCT/AU2017/050879 WO2018032057A1 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019528271A JP2019528271A (ja) | 2019-10-10 |
| JP2019528271A5 true JP2019528271A5 (cg-RX-API-DMAC7.html) | 2020-05-14 |
Family
ID=61195904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508842A Pending JP2019528271A (ja) | 2016-08-19 | 2017-08-18 | ウイルスワクチン |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10905759B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3500280A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019528271A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190050787A (cg-RX-API-DMAC7.html) |
| CN (1) | CN109862909A (cg-RX-API-DMAC7.html) |
| AR (1) | AR110624A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017313450B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3265584A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2019000405A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL264893B (cg-RX-API-DMAC7.html) |
| MA (1) | MA45994A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019001919A (cg-RX-API-DMAC7.html) |
| MY (1) | MY200887A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ750578A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201900814QA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI728173B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018032057A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201900641B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3117378A1 (en) * | 2018-10-22 | 2020-04-30 | Icellkealex Therapeutics Llc | Mutant vaccinia viruses and use thereof |
| US20210299245A1 (en) * | 2020-03-31 | 2021-09-30 | Sementis Limited | Attenuated poxvirus vector based vaccine for protection against covid-19 |
| CN112362877B (zh) * | 2020-10-27 | 2024-04-12 | 江苏先声医学诊断有限公司 | 一种mbp重组蛋白以及其应用 |
| KR102864666B1 (ko) * | 2025-04-21 | 2025-09-29 | 대한민국 | 치쿤구니아 바이러스 외피 재조합 dna를 포함하는 백신 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69534289T2 (de) * | 1994-04-29 | 2006-04-27 | Baxter Healthcare S.A. | Rekombinante Pockenviren mit fremden Polynukleotiden in wichtigen Regionen |
| CN1418951A (zh) * | 2001-05-23 | 2003-05-21 | 广州绿健生物技术有限公司 | 生产rna病毒和基于rna病毒的载体颗粒的组合物及方法 |
| EP1407033B1 (en) * | 2002-05-16 | 2006-01-11 | Bavarian Nordic A/S | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| EP2269618A1 (en) * | 2002-08-12 | 2011-01-05 | Jennerex Biotherapeutics ULC | An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| KR20040015624A (ko) | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물 |
| WO2004074493A1 (en) * | 2003-02-18 | 2004-09-02 | Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh | Recombinant mva and method for generation thereof |
| EP1518932A1 (en) * | 2003-09-29 | 2005-03-30 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Modified vaccinia virus Ankara (MVA) mutant and use thereof |
| EP1683870A1 (en) * | 2005-01-24 | 2006-07-26 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Vaccines based on the use of MVA |
| GB201006405D0 (en) * | 2010-04-16 | 2010-06-02 | Isis Innovation | Poxvirus expression system |
| EP2618840A2 (en) * | 2010-09-23 | 2013-07-31 | Baxter International Inc. | Recombinant viral vectors and methods for inducing an immune response to yellow fever virus |
| WO2014138824A1 (en) | 2013-03-15 | 2014-09-18 | Sementis Limited | Immune modulation |
| PL3063278T3 (pl) * | 2013-11-01 | 2018-08-31 | Sementis Limited | Wytwarzanie wektora wirusowego |
| WO2016086980A1 (en) * | 2014-12-02 | 2016-06-09 | Consejo Superior De Investigaciones Cientificas | Vaccine composition |
| BR112018015696A2 (pt) * | 2016-02-03 | 2018-12-26 | Geovax Inc | composições e métodos para gerar uma resposta imune para um flavivírus |
-
2017
- 2017-08-18 MX MX2019001919A patent/MX2019001919A/es unknown
- 2017-08-18 CA CA3265584A patent/CA3265584A1/en active Pending
- 2017-08-18 SG SG11201900814QA patent/SG11201900814QA/en unknown
- 2017-08-18 IL IL264893A patent/IL264893B/en unknown
- 2017-08-18 AR ARP170102311A patent/AR110624A1/es unknown
- 2017-08-18 EP EP17840633.6A patent/EP3500280A4/en not_active Withdrawn
- 2017-08-18 US US16/325,539 patent/US10905759B2/en active Active
- 2017-08-18 JP JP2019508842A patent/JP2019528271A/ja active Pending
- 2017-08-18 MA MA045994A patent/MA45994A/fr unknown
- 2017-08-18 NZ NZ750578A patent/NZ750578A/en unknown
- 2017-08-18 MY MYPI2019000845A patent/MY200887A/en unknown
- 2017-08-18 CA CA3034282A patent/CA3034282A1/en active Pending
- 2017-08-18 CN CN201780063830.0A patent/CN109862909A/zh active Pending
- 2017-08-18 AU AU2017313450A patent/AU2017313450B2/en active Active
- 2017-08-18 WO PCT/AU2017/050879 patent/WO2018032057A1/en not_active Ceased
- 2017-08-18 EP EP23215911.1A patent/EP4331676A3/en active Pending
- 2017-08-18 KR KR1020197007662A patent/KR20190050787A/ko not_active Ceased
- 2017-08-18 TW TW106128111A patent/TWI728173B/zh not_active IP Right Cessation
-
2019
- 2019-01-30 ZA ZA2019/00641A patent/ZA201900641B/en unknown
- 2019-02-14 CL CL2019000405A patent/CL2019000405A1/es unknown
-
2020
- 2020-12-22 US US17/130,165 patent/US20210113684A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6818797B2 (ja) | 強靭なｔ細胞用のｐｒ１３．５プロモータ及び抗体応答 | |
| JP2019528271A5 (cg-RX-API-DMAC7.html) | ||
| Verardi et al. | A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication | |
| Herbert et al. | Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR | |
| AU2001286109B2 (en) | Use of replication-deficient poxvirus vector to boost CD4+T cell immune response to antigen | |
| JP2016510989A5 (cg-RX-API-DMAC7.html) | ||
| Zhu | SARS immunity and vaccination | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| JP2011041578A5 (cg-RX-API-DMAC7.html) | ||
| Mendes et al. | Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1 | |
| JP4700907B2 (ja) | ウイルス増殖方法 | |
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| Weyer et al. | Poxvirus-vectored vaccines for rabies—a review | |
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| EP1881845A2 (en) | Nipah virus vaccines | |
| RU2015115785A (ru) | Мсн-специфичные пептиды со смещенной рамкой считывания (псрс) для предотвращения и лечения рака | |
| JP2010523138A5 (cg-RX-API-DMAC7.html) | ||
| Phelps et al. | Comparative efficacy of intramuscular and scarification routes of administration of live smallpox vaccine in a murine challenge model | |
| JP2023528984A (ja) | コロナウイルス病に対する組換え修飾ワクシニアウイルスアンカラ（ｍｖａ）ワクチン | |
| Kennedy et al. | T‐Cell epitope discovery for variola and vaccinia viruses | |
| Bennett et al. | Recombinant vaccinia viruses protect against Clostridium perfringens α-toxin | |
| EA200701801A1 (ru) | Применение модифицированных поксвирусов для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов | |
| Akkutay-Yoldar et al. | Diagnosis and phylogenetic analysis of orf virus in Aleppo and Saanen goats from an outbreak in Turkey | |
| Meseda et al. | Percutaneous vaccination as an effective method of delivery of MVA and MVA-vectored vaccines | |
| RU2019107582A (ru) | Вирусные вакцины |